🔎 Trials Near Me

Akèy › Depresyon › Florid › Orlando

Etid klinik pou Depresyon nan Orlando, FL

17 etid pou Depresyon ap chèche patisipan nan sit nan ak bò kote Orlando (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)

Ap rekriteFaz 2
  • Clinical Neuroscience Solutions Inc. - Orlando, Orlando
  • K2 Medical Research - Maitland, Maitland · 6 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07621237

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

Ap rekriteFaz 3
  • Accel Research Sites - Maitland, Maitland · 6 mi lwen
Laj 18 a 85 · Tout sèks · Mizajou Sep 25, 2026 · NCT06793397

A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)

Ap rekriteFaz 2
  • Seaport Investigator Site, Orlando
Laj 18 a 65 · Tout sèks · Mizajou Sep 14, 2026 · NCT07065240

A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression

Ap rekriteFaz 2
  • Draig Clinical Site, Orlando
  • Draig Clinical Site, Orlando
Laj 18 a 75 · Tout sèks · Mizajou Sep 2, 2026 · NCT07610473

A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

Ap rekriteFaz 2
  • Draig Clinical Site, Orlando
Laj 18 a 75 · Tout sèks · Mizajou Aug 26, 2026 · NCT07300969

NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Ap rekriteFaz 3
  • Neurocrine Clinical Site, Maitland · 6 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 10, 2026 · NCT06963021

A Study of Brenipatide in Adult Participants With Major Depressive Disorder

Ap rekriteFaz 3
  • Charter Research - Orlando, Orlando
  • K2 Medical Research - Maitland, Maitland · 6 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Aug 6, 2026 · NCT07412756

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

Ap rekriteFaz 3
  • Clinical Neuroscience Solutions, Inc., Orlando
Laj 18 a 74 · Tout sèks · Mizajou Aug 3, 2026 · NCT06775379

Adapting Single Sessions Interventions for Type 1 Diabetes

Ap rekrite
  • Nemours Children's Hospital - FL, Orlando
Laj 12 a 17 · Tout sèks · Mizajou Jul 24, 2026 · NCT06752369

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Ap rekriteFaz 3
  • Neurocrine Clinical Site, Maitland · 6 mi lwen
  • Neurocrine Clinical Site, Maitland · 6 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jul 24, 2026 · NCT06966401

TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age

Ap rekriteEtid obsèvasyon
  • Nemours Foundation, Orlando
18 Months – 11 Years · Tout sèks · Mizajou Jul 6, 2026 · NCT07048574

BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Sexual Function Among Perimenopausal and Postmenopausal Women

Ap rekrite
  • Luxury Psychiatry Clinic, Winter Garden · 13 mi lwen
Laj 40 ak plis · Fanm · Mizajou Feb 17, 2026 · NCT07413705

Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Ap rekriteFaz 3
  • Neurocrine Clinical Site, Maitland · 6 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 29, 2025 · NCT06786624

A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

Ap rekriteFaz 4
  • Clinical Research Site, Orlando
  • Clinical Research Site, Orlando
  • Clinical Research Site, Orlando
Laj 18 a 65 · Tout sèks · Mizajou Jan 23, 2025 · NCT06223880

The Lake Nona Life Project

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Lake Nona Institute, Orlando
Laj 18 a 110 · Tout sèks · Mizajou Dec 6, 2024 · NCT02533804

Etid Depresyon nan lòt vil

Lòt etid nan Orlando

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.